| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |